Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cyproheptadine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 4/20 | 1.00 |
| ▸ | SETD7 | Q8WTS6 | 7/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 5/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 5/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 5/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 5/20 | 1.00 |
| ▸ | HTR1A | P08908 | 4/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 4/20 | 1.00 |
| ▸ | DRD1 | P21728 | 4/20 | 1.00 |
| ▸ | DRD3 | P35462 | 4/20 | 1.00 |
| ▸ | HTR2A | P28223 | 4/20 | 1.00 |
| ▸ | HTR2C | P28335 | 4/20 | 1.00 |
| ▸ | HTR2B | P41595 | 4/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 3/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 3/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 3/20 | 1.00 |
| ▸ | DRD2 | P14416 | 3/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyproheptadine SCHEMBL29369949 | 1.00 | SETD7 (1.00) | SETD7CHRM2CHRM1ADRA1AKCNH2 | |
| Cyproheptadine SCHEMBL7923153 | 1.00 | SETD7 (1.00) | SETD7CHRM2CHRM1ADRA1AKCNH2 | |
| Cyproheptadine SCHEMBL29380652 | 0.98 | LMNA (1.00) | SETD7CHRM2CHRM1ADRA1AKCNH2 | |
| Cyproheptadine SCHEMBL30772122 | 0.98 | LMNA (1.00) | SETD7CHRM2CHRM1ADRA1AKCNH2 | |
| Cyproheptadine SCHEMBL20610743 | 0.98 | LMNA (1.00) | SETD7CHRM2CHRM1ADRA1AKCNH2 | |
| Cyproheptadine SCHEMBL5500354 | 0.98 | LMNA (1.00) | SETD7CHRM2CHRM1ADRA1AKCNH2 | |
| Cyproheptadine SCHEMBL11779784 | 0.98 | SETD7 (0.96) | SETD7CHRM2CHRM1ADRA1AKCNH2 | |
| Cyproheptadine SCHEMBL41842 | 0.98 | LMNA (1.00) | SETD7CHRM2CHRM1ADRA1AKCNH2 | |
| Cyproheptadine SCHEMBL9934753 | 0.96 | LMNA (0.97) | SETD7CHRM2CHRM1ADRA1AKCNH2 | |
| Cyproheptadine SCHEMBL3005524 | 0.96 | SETD7 (0.93) | SETD7CHRM2CHRM1ADRA1AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 19009 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-20260115192-A1 | PHARMACEUTICAL COMPOSITIONS | SHENZHEN PHARMACIN CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-12605402-B2 | Therapeutic uses of oxidizing hypotonic acid solutions | APR APPLIED PHARMA RESEARCH SA (CH) | 2026-04-21 | — | — | US | claimed |
| EP-4725483-A1 | COMBINATION COMPRISING AT LEAST ONE 5-HT2A RECEPTOR ANTAGONIST AND AT LEAST ONE 5-HT3 RECEPTOR ANTAGONIST AND ITS MEDICAL USE | Université de Bordeaux (FR) | 2026-04-15 | — | — | EP | claimed |
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-12569451-B2 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | Cellartgen Inc. (KR) | 2026-03-10 | — | — | US | claimed |
| WO-2026042047-A1 | COMPOSITIONS AND ARTICLES COMPRISING REVERSIBLE COMPLEXES OF CROSSLINKED CARRAGEENAN | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| US-12550885-B2 | Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells | UNIVERSITY OF CINCINNATI (US) | 2026-02-17 | — | — | US | claimed |
| EP-4691556-A2 | HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF | H. Lundbeck A/S (DK) | 2026-02-11 | — | — | EP | claimed |
| EP-4691568-A2 | LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF | Eye Therapies, LLC (US) | 2026-02-11 | — | — | EP | claimed |
| EP-0036138-B1 | COMPOSITION OF MATTER FOR TOPICAL APPLICATION COMPRISING A BIO-AFFECTING AGENT AND N,N-DIETHYL-M-TOLUAMIDE | MERCK & CO. INC. (US) | 1985-08-28 | — | — | EP | claimed |
| US-4524072-A | Reduction of stroke damage | ZIVIN JUSTIN A | 1985-06-18 | — | — | US | claimed |
| US-4444778-A | ANTISEROTONINE AGENTS | COUGHLIN SHAUN R | 1984-04-24 | — | — | US | claimed |
| US-4444780-A | Method for treating atopic dermatitis | ORTHO PHARMACEUTICAL CORPORATION (US) | 1984-04-24 | — | — | US | claimed |
| EP-0104782-A2 | A pharmaceutical composition for topical application for treating atopic dermatitis | ORTHO PHARMACEUTICAL CORPORATION (US) | 1984-04-04 | — | — | EP | claimed |
| US-4165376-A | CYPROHEPTADINE | LAKE SHORE ROENTGENOLOGY, LTD. (US) | 1979-08-21 | — | — | US | claimed |
| US-4153700-A | Treatment of the acute after-effects resulting from alcohol ingestion | LAKE SHORE ROENTGENOLOGY LTD. (US) | 1979-05-08 | — | — | US | claimed |
| US-4104382-A | (((THIAZOLYL-, ISOTHIAZOLYL- OR PYRIDYLALKYL)THIO)ALKYL)GUANIDINE | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1978-08-01 | — | — | US | claimed |
| US-4000302-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-12-28 | — | — | US | claimed |
| US-3968115-A | OR 11)-BROMO-10,11-DIHYDRO-5H-DIBENZO(A,D)-CYCLOHEPTEN-5-YLIDENE PIPERIDINE COMPOUNDSANTIHISTAMINE, APPETITE STIMULANT | MERCK & CO., INC. (US) | 1976-07-06 | — | — | US | claimed |